EZH2 enzyme activity in tumor cells is recognized ... “These encouraging preclinical results have prompted us to initiate pilot studies of an EZH2 inhibitor with immunotherapies in lymphoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback